Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2023 Jan 13;12:1125641. doi: 10.3389/fonc.2022.1125641

Corrigendum: MRI radiomics predicts progression-free survival in prostate cancer

Yushan Jia 1, Shuai Quan 2, Jialiang Ren 2, Hui Wu 3,*, Aishi Liu 3,*, Yang Gao 3, Fene Hao 3, Zhenxing Yang 3, Tong Zhang 1, He Hu 1
PMCID: PMC9880521  PMID: 36713503

In the published article, there was an error in affiliation 3. Instead of “Department of Radiology, Inner Mongolia International Hospital, Hohhot, China”, it should be “Department of Radiology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES